Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive.
Subcutaneous and intracranial VMDk tumours were treated with photodynamic therapy (PDT) using a new sensitiser, m-THPP. Subcutaneous tumours were highly sensitive to PDT but intracranial tumours were much more resistant, requiring a 30-fold increase in sensitiser dose to produce equivalent levels of...
Main Authors: | Lindsay, E. A., Berenbaum, M. C., Bonnett, R., Thomas, D. G. |
---|---|
Format: | Online |
Language: | English |
Published: |
1991
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971766/ |
Similar Items
-
The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.
by: Lilge, L., et al.
Published: (1996) -
The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy
Published: (1996) -
Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
by: Gossner, L., et al.
Published: (1991) -
Photodynamic therapy of ascites tumours within the peritoneal cavity.
by: Tochner, Z., et al.
Published: (1986) -
Tumour to Tumour Metastasis of Malignant Melanoma to Intracranial Tumour
by: Shariff, Zakir, et al.
Published: (2009)